Specialties Medical OncologyQuestion

How do you approach need for adjuvant therapy after R0 resection of breast angiosarcoma?

4

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Which patient characteristics or clinical factors guide the decision to use Doxorubicin and Trabectedin as first-line treatment for metastatic or unresectable leiomyosarcoma?

How would you treat an unresectable epithelioid angiosarcoma invading the cavernous sinus, wrapping around the carotid artery?

If PEAK (bezuclastinib + sunitinib) is approved, how would it influence your second-line treatment strategy for patients with advanced KIT-mutant GIST following imatinib failure?

Assuming regulatory approval, what role do you foresee for varegacestat (RINGSIDE) in the management of progressive desmoid tumors, particularly in relation to existing systemic treatment options?

What are your top takeaways in Sarcoma from ASCO 2026?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.